Breath Test May Help Diagnose Irritable Bowel Syndrome
By LabMedica International staff writers Posted on 17 May 2016 |
There is currently no specific diagnostic & monitoring test for irritable bowel syndrome (IBS) and no potentially reliable biomarkers have been identified until now. Using a novel metabolomic approach, researchers have identified a combination of substances in the breath that, when measured together, accurately distinguished IBS patients from people without the condition.
In a case-control study, a team of investigators, led by senior author Prof. Frederik-Jan van Schooten, Maastricht University Medical Centre (MUMC+; Maastricht, The Netherlands), analyzed a set of 16 volatile organic compounds (VOCs) in breath samples from a clinical cohort of 170 IBS patients and 153 healthy controls. The potential diagnostic VOC-biomarker set was then also tested on a cohort of 1307 participants from the general population.
The VOCs set correctly predicted 89.4% of the IBS patients and 73.3% of the healthy controls. Furthermore, the results of the breath test were particularly abnormal when patients' intestinal symptoms were most severe.
The study identified a set of 16 breath-based biomarkers for IBS. The VOC-biomarker set correlated significantly with GI symptoms and demonstrated the potential use of breath analysis in the diagnosis and monitoring of IBS, and a possible application of VOC analyses for screening the general or at-risk population.
"Now we know which chemicals in breath have diagnostic information that we can use to develop noninvasive tools to follow the disease and to steer therapeutic interventions," said senior author Prof. van Schooten, "This will definitely make a difference in quality of life for patients suffering from this functional gastrointestinal disorder."
The study, by Baranska A et al, was published May 2, 2016, in the journal Alimentary Pharmacology and Therapeutics.
Related Links:
Maastricht University Medical Centre
In a case-control study, a team of investigators, led by senior author Prof. Frederik-Jan van Schooten, Maastricht University Medical Centre (MUMC+; Maastricht, The Netherlands), analyzed a set of 16 volatile organic compounds (VOCs) in breath samples from a clinical cohort of 170 IBS patients and 153 healthy controls. The potential diagnostic VOC-biomarker set was then also tested on a cohort of 1307 participants from the general population.
The VOCs set correctly predicted 89.4% of the IBS patients and 73.3% of the healthy controls. Furthermore, the results of the breath test were particularly abnormal when patients' intestinal symptoms were most severe.
The study identified a set of 16 breath-based biomarkers for IBS. The VOC-biomarker set correlated significantly with GI symptoms and demonstrated the potential use of breath analysis in the diagnosis and monitoring of IBS, and a possible application of VOC analyses for screening the general or at-risk population.
"Now we know which chemicals in breath have diagnostic information that we can use to develop noninvasive tools to follow the disease and to steer therapeutic interventions," said senior author Prof. van Schooten, "This will definitely make a difference in quality of life for patients suffering from this functional gastrointestinal disorder."
The study, by Baranska A et al, was published May 2, 2016, in the journal Alimentary Pharmacology and Therapeutics.
Related Links:
Maastricht University Medical Centre
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines